1. Genetics and mechanisms of glycopeptide resistance in enterococci;Arthur M.;Antimicrob. Agents Chemother.,1993
2. Barbachyn M. R. S. J. Brickner C. W. Ford S. Glickman K. C. Grega S. K. Hendges J. O. Kilburn D. S. Toops D. A. Ulanowicz and G. E. Zurenko. 1995. Synthesis and structure-activity relationships of new troponesubstituted oxazolidinone antibacterial agents abstr. F206 p. 149. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
3. Bostic G. M. B. Perri L. A. Thal and M. J. Zervos. 1995. Comparative in-vitro and bactericidal activity of oxazolidinone antibiotics against multidrug resistant enterococci abstr. F219 p. 151. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
4. Brickner S. J. D. K. Hutchinson M. R. Barbachyn S. A. Garmon K. C. Grega S. K. Hendges P. R. Manninen D. S. Toops D. A. Ulanowicz J. O. Kilburn S. Glickman G. E. Zurenko and C. W. Ford. 1995. Synthesis of U-100592 and U-100766 two new oxazolidinone antibacterial agents in clinical trials for treatment of multiply resistant gram positive infections abstr. F208 p. 149. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
5. In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms;Collins L. A.;Antimicrob. Agents Chemother.,1993